The Risk Calculator
How can we protect patients against drug–drug interactions and adverse drug reactions?
Maryam Mahdi | | Quick Read
Teaming up with leaders from across the pharmaceutical industry, Elsevier has developed an updated drug–drug interaction risk calculator (DDIRC) to help lower the incidence of adverse drug reactions (ADRs). The DDIRC was developed as part of a two-year collaboration with Boehringer Ingelheim, Eli Lilly, Pierre Fabre, Sanofi, Servier, and several other industry players, to help drug metabolism-pharmacokinetic (DMPK) and clinical pharmacology scientists improve patient safety and outcomes – and reduce risk during pharmaceutical development.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.